82
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Pro-inflammatory cytokine inhibition in the primate using microencapsulated antisense oligomers to NF-κB

, , , , &
Pages 337-348 | Received 28 May 2006, Accepted 01 Sep 2006, Published online: 08 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Neil Patel, Richard T. Addo, Ruhi Ubale, Mohammed Nasir Uddin, Martin D’Souza & Lynetta Jobe. (2014) The effect of antisense to NF-κB in an albumin microsphere formulation on the progression of left-ventricular remodeling associated with chronic volume overload in rats. Journal of Drug Targeting 22:9, pages 796-804.
Read now
Gerald G Enriquez, Syed AA Rizvi, Martin J D’Souza & Duc P Do. (2013) Formulation and evaluation of drug-loaded targeted magnetic microspheres for cancer therapy. International Journal of Nanomedicine 8, pages 1393-1402.
Read now
Mohammad Nasir Uddin, Neil J. Patel, Tuhin Bhowmik, Bernadette D’Souza, Archana Akalkotkar, Frank Etzlar, Carl William Oettinger & Martin D’Souza. (2013) Enhanced bioavailability of orally administered antisense oligonucleotide to nuclear factor kappa B mRNA after microencapsulation with albumin. Journal of Drug Targeting 21:5, pages 450-457.
Read now
Carl W. Oettinger & Martin J. D'souza. (2012) Microencapsulated drug delivery: a new approach to pro-inflammatory cytokine inhibition. Journal of Microencapsulation 29:5, pages 455-462.
Read now
Mohammad N. Uddin, Aladin Siddiq, Carl W. Oettinger & Martin J. D’Souza. (2011) Potentiation of pro-inflammatory cytokine suppression and survival by microencapsulated dexamethasone in the treatment of experimental sepsis. Journal of Drug Targeting 19:9, pages 752-760.
Read now
Carl W. Oettinger & Martin J. D'Souza. (2010) Synergism in survival to endotoxic shock in rats given microencapsulated CNI-1493 and antisense oligomers to NF-κB. Journal of Microencapsulation 27:4, pages 372-376.
Read now
Sanjay G. Gayakwad, Naveen K. Bejugam, Nima Akhavein, Nasir A. Uddin, Carl E Oettinger & Martin J. D'Souza. (2009) Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-κB encapsulated albumin microspheres. Journal of Microencapsulation 26:8, pages 692-700.
Read now
Rodney C. Siwale, George K. Yeboah, Richard Addo, Carl W. Oettinger & Martin J. D’Souza. (2009) The effect of intracellular antioxidant delivery (catalase) on hydrogen peroxide and proinflammatory cytokine synthesis: a new therapeutic horizon. Journal of Drug Targeting 17:9, pages 710-718.
Read now
Rodney C. Siwale, Carl W. Oettinger, Richard Addo, Aladin Siddig & Martin J. D’Souza. (2009) The effect of intracellular delivery of catalase and antisense oligonucleotides to NF-κB using albumin microcapsules in the endotoxic shock model. Journal of Drug Targeting 17:9, pages 701-709.
Read now
Pawan K. Angra, Carl Oettinger, S. Balakrishna Pai & Martin J. D’Souza. (2009) Amphotericin B microspheres: A therapeutic approach to minimize toxicity while maintaining antifungal efficacy. Journal of Microencapsulation 26:7, pages 580-587.
Read now
Nima Akhavein, Carl W. Oettinger, Sanjay G. Gayakwad, Richard T. Addo, Naveen K. Bejugam, John D. Bauer, Duc Do, Stanley H. Pollock & Martin J. D'souza. (2009) Treatment of adjuvant arthritis using microencapsulated antisense NF-κB oligonucleotides. Journal of Microencapsulation 26:3, pages 223-234.
Read now

Articles from other publishers (8)

Aboagyewaah Oppong-Damoah, Rokon Uz Zaman, Martin J. D'Souza & Kevin Sean Murnane. (2019) Nanoparticle encapsulation increases the brain penetrance and duration of action of intranasal oxytocin. Hormones and Behavior 108, pages 20-29.
Crossref
Rokon Uz Zaman, Nihal S. Mulla, Keegan Braz Gomes, Cherilyn D'Souza, Kevin Sean Murnane & Martin J. D'Souza. (2018) Nanoparticle formulations that allow for sustained delivery and brain targeting of the neuropeptide oxytocin. International Journal of Pharmaceutics 548:1, pages 698-706.
Crossref
Ruhi V. Ubale, Prathap Nagaraja Shastri, Carl Oettinger & Martin J. D’Souza. (2018) Pulmonary Administration of Microparticulate Antisense Oligonucleotide (ASO) for the Treatment of Lung Inflammation. AAPS PharmSciTech 19:4, pages 1908-1919.
Crossref
V. G. Metelev, E. A. Kubareva & T. S. Oretskaya. (2013) Regulation of activity of transcription factor NF-κB by synthetic oligonucleotides. Biochemistry (Moscow) 78:8, pages 867-878.
Crossref
Rodney Siwale, Fred Meadows, Vicky V Mody & Samit Shah. (2013) Formulation and drug-content assay of microencapsulated antisense oligonucleotide to NF- κ B using ATR-FTIR . Advances in Natural Sciences: Nanoscience and Nanotechnology 4:3, pages 035002.
Crossref
Pawan Kumar Angra, Syed Asad Ali Rizvi, Carl William Oettinger & Martin Joaquim D’Souza. (2011) Novel approach for preparing nontoxic stealth microspheres for drug delivery. European Journal of Chemistry 2:2, pages 125-129.
Crossref
D. J. Stearns-Kurosawa, Valta Collins, Scott Freeman, Vernon L. Tesh & Shinichiro Kurosawa. (2010) Distinct Physiologic and Inflammatory Responses Elicited in Baboons after Challenge with Shiga Toxin Type 1 or 2 from Enterohemorrhagic Escherichia coli . Infection and Immunity 78:6, pages 2497-2504.
Crossref
Mohammad N. Uddin, Duc P. Do, S. Balakrishna Pai, Sanjay Gayakwad, Carl W. Oettinger & Martin J. D'Souza. (2009) A methodology for quantitation and characterization of oligonucleotides in albumin microspheres. The Analyst 134:7, pages 1483.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.